8-K/A XBRL

FORM 8-K/A

Company: Cellectar Biosciences, Inc.
Filed: June 20, 2023
Period of Report: June 14, 2023
Accession Number: 0001104659-23-072483

View Document ↗ View on SEC.gov ↗